Table 1 Baseline comparison between the training cohort and validation cohort.
Variables | Total (n = 468) | Training cohort (n = 327) | Validation cohort (n = 141) | Statistic | P |
|---|---|---|---|---|---|
Age(months), M (Q1, Q3) | 129.50 (48.00, 156.00) | 127.00 (48.00, 156.00) | 132.00 (36.00, 156.00) | Z=-0.12 | 0.906 |
BMI(kg/m2), M (Q1, Q3) | 16.48 (15.21, 18.40) | 16.45 (15.21, 18.38) | 16.83 (15.40, 18.48) | Z=-0.91 | 0.364 |
Duration of symptoms (hours), M (Q1, Q3) | 27.00 (10.00, 62.00) | 27.00 (10.00, 51.00) | 28.00 (13.00, 76.00) | Z=-1.74 | 0.081 |
Hematological parameters | |||||
WBC(109 /L), M (Q1, Q3) | 10.67 (8.61, 13.15) | 10.73 (8.71, 13.27) | 10.33 (8.57, 13.10) | Z=-0.92 | 0.358 |
Neutrophil(109 /L), M (Q1, Q3) | 6.77 (5.04, 8.64) | 6.97 (5.26, 8.95) | 6.72 (4.95, 8.08) | Z=-0.99 | 0.323 |
Lymphocyte(109 /L), M (Q1, Q3) | 2.37 (1.63, 3.54) | 2.30 (1.60, 3.71) | 2.42 (1.72, 3.40) | Z=-0.54 | 0.589 |
Monocyte(109 /L), M (Q1, Q3) | 0.64 (0.43, 0.90) | 0.64 (0.44, 0.90) | 0.62 (0.41, 0.90) | Z=-0.45 | 0.650 |
Eosinophil(109 /L), M (Q1, Q3) | 0.06 (0.02, 0.19) | 0.07 (0.02, 0.19) | 0.10 (0.02, 0.22) | Z=-0.94 | 0.340 |
Basophil(109 /L), M (Q1, Q3) | 0.02 (0.02, 0.04) | 0.02 (0.02, 0.04) | 0.03 (0.02, 0.04) | Z=-0.49 | 0.625 |
Platelet(109 /L), M (Q1, Q3) | 285.00 (231.00, 331.25) | 286.00 (236.00, 330.00) | 282.00 (219.00, 335.00) | Z=-1.16 | 0.245 |
MPV(fl.), Mean ± SD | 10.09 ± 1.34 | 10.04 ± 1.34 | 10.20 ± 1.33 | t = 1.21 | 0.228 |
PCT(%), M (Q1, Q3) | 0.28 (0.25, 0.33) | 0.28 (0.25, 0.33) | 0.28 (0.25, 0.33) | Z=-0.28 | 0.778 |
PDW(fl.), M (Q1, Q3) | 12.80 (10.60, 15.80) | 12.90 (10.55, 15.70) | 12.70 (10.60, 15.90) | Z=-0.21 | 0.836 |
CRP(mg/L), M (Q1, Q3) | 3.73 (0.60, 10.20) | 3.60 (0.58, 10.20) | 4.50 (0.80, 11.50) | Z=-1.44 | 0.149 |
TWIST score grading, n (%) | χ2=0.16 | 0.688 | |||
Intermediate risk | 229 (48.93) | 162 (49.54) | 67 (47.52) | ||
High risk | 239 (51.07) | 165 (50.46) | 74 (52.48) | ||
Affected side, n (%) | χ2=0.01 | 0.917 | |||
Left | 347 (74.15) | 242 (74.01) | 105 (74.47) | ||
Right | 121 (25.85) | 85 (25.99) | 36 (25.53) | ||
Season of occurrence, n (%) | χ2=0.66 | 0.882 | |||
Spring | 91 (19.44) | 61 (18.65) | 30 (21.28) | ||
Summer | 130 (27.78) | 92 (28.13) | 38 (26.95) | ||
Autumn | 97 (20.73) | 70 (21.41) | 27 (19.15) | ||
Winter | 150 (32.05) | 104 (31.80) | 46 (32.62) | ||
Time of occurrence, n (%) | χ2=0.25 | 0.617 | |||
Daytime | 336 (71.79) | 237 (72.48) | 99 (70.21) | ||
Nighttime | 132 (28.21) | 90 (27.52) | 42 (29.79) | ||
TT of UDT, n (%) | χ2=0.00 | 0.992 | |||
Yes | 53 (11.32) | 37 (11.31) | 16 (11.35) | ||
No | 415 (88.68) | 290 (88.69) | 125 (88.65) | ||
Testicular echotexture, n (%) | χ2=0.13 | 0.715 | |||
Homogeneous | 72 (15.38) | 49 (14.98) | 23 (16.31) | ||
Nonhomogeneous | 396 (84.62) | 278 (85.02) | 118 (83.69) | ||
Blood flow signal, n (%) | χ2=0.32 | 0.570 | |||
Visible | 131 (27.99) | 89 (27.22) | 42 (29.79) | ||
Invisible | 337 (72.01) | 238 (72.78) | 99 (70.21) | ||
Type of torsion, n (%) | χ2=0.01 | 0.916 | |||
Intra-vaginal | 444 (94.87) | 310 (94.80) | 134 (95.04) | ||
Extra-vaginal | 24 (5.13) | 17 (5.20) | 7 (4.96) | ||
Degree of torsion (°), M (Q1, Q3) | 360.00 (270.00, 720.00) | 360.00 (270.00, 720.00) | 360.00 (270.00, 720.00) | Z=-0.51 | 0.613 |
Direction of torsion, n (%) | χ2=0.67 | 0.415 | |||
Clockwise | 186 (39.74) | 126 (38.53) | 60 (42.55) | ||
Anticlockwise | 282 (60.26) | 201 (61.47) | 81 (57.45) | ||